The Company for Life's Journey
Latest News

Merriman Investor Summit 2012

January 27, 2012

Website Update

Proteonomix, Inc. announced today that it will be presenting at the Investor Summit 2012 on February 1, 2012, sponsored by Merriman Capital at the Intercontinental Time Square Hotel in New York City.

Read Full Story >

UMK-121 is IRB Approved

January 4, 2012

New Subsidiary XGen Medical LLC.

Proteonomix, Inc. announced today that the Company's clinical trial of UMK-121 has received IRB (Institutional Review Board) approval and is now ready for the recruitment of patients.

Read Full Story >

Payment complete for UMK-121

December 27, 2011

International Strategic Joint Ventures

Proteonomix, Inc. announced today that it has completed all payments required from Proteonomix to commence a Clinical Study entitled "UMK-121 in Patients with Liver Disease."

Read Full Story >
Media Inquiries
Order a Brochure
Company
Get Involved
Inside Proteonomix
Contact

Home

What We Do

Who We Are

Affiliates

Cord Blood Bank

Investors

Partners

Careers

Order Brochure

News + Events

Technology

Health Care Pratitioners

Media Inquiries

Proteoderm, Inc.

187 Mill Lane
Mountainside, NJ 07092-2909

p. 973.544.6116
e. info@proteonomix.com

© Copyright 2012 Proteonomix, Inc. Site Map